An ibuprofen-antagonized plasmin inhibitor released by human endothelial cells.
Serum-free culture medium harvested from endothelial cell monolayer cultures derived from human scars and dermis was examined for inhibition of fibrinolysis using a fibrin plate assay. Human cultured fibroblasts and smooth muscle cells did not produce any detectable inhibitory activity. The inhibitor is spontaneously released from the cultured endothelial cells over time. In the fibrin plate assay of plasmin-induced fibrinolysis, one nonsteroidal antiinflammatory (NSAI) drug, ibuprofen, was demonstrated to antagonize the inhibition of fibrinolysis. The antagonistic activity of ibuprofen appears unrelated to its NSAI drug activity because other NSAI drugs such as indomethacin and tolmetin have minimal antagonistic activity. Heating the cultured endothelial cells to 42 degrees C stimulates greater release of the inhibitor in a shorter period of time. This plasmin inhibitor, which is produced by endothelial cells, may contribute to postburn vascular occlusion, leading to secondary progressive necrosis in burn-traumatized patients.
Rockwell
W B
WB
Wound Healing Laboratory, Shriners Burns Institute, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Ehrlich
H P
HP
D000933:Antifibrinolytic Agents / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002056:Burns / Q000201:enzymology; D002478:Cells, Cultured; D002921:Cicatrix / Q000201:enzymology*; D004727:Endothelium / Q000201:enzymology*; D005342:Fibrinolysis; D006358:Hot Temperature; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D012867:Skin / Q000201:enzymology*; D013927:Thrombosis / Q000209:etiology; D014046:Tolmetin / Q000494:pharmacology
D000933:Antifibrinolytic Agents; D014046:Tolmetin; D007052:Ibuprofen; D007213:Indomethacin